CBIZ (CBZ) On Activist Pressure And Index Shifts Looks Modestly Undervalued
Investor attention on CBIZ (CBZ) has intensified after Reference Equity publicly urged the company to halt share repurchases, resume acquisitions, and raise equity capital, alongside recent shifts between several Russell value and growth indices.
See our latest analysis for CBIZ.
CBIZ's recent 2.61% 1 day share price return and 39.81% 90 day share price return indicate improving short term momentum. However, the year to date share price return and 1 year total shareholder return are both lower.
If this kind of catalyst driven move has your attention, it could be a good time to broaden your watchlist with the 18 top founder-led companies
After CBIZ's recent move, the share price sits at $37.79 against analyst and intrinsic estimates that point higher. So where does a reasonable view of fair value actually land across that spread?
Most Popular Narrative: 8% Undervalued
At a last close of $37.79 versus a narrative fair value of $41.00, CBIZ is framed as modestly undervalued, with analysts focused on execution and capital allocation.
The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle-market segments; this is expected to fuel higher future revenue growth and structural margin expansion as integration synergies are realized.
Want to see how a larger advisory platform, tighter margins, and a different future earnings mix are stitched together into one valuation story? The most followed narrative leans on a specific path for revenue, profitability and the price investors might pay for those future earnings, and the detail sits in the full breakdown.
Result: Fair Value of $41 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, CBIZ's reliance on acquisitions and higher leverage after the Marcum deal, together with pricing pressure in key services, could challenge this fair value story.
Find out about the key risks to this CBIZ narrative.
Next Steps
With CBIZ's mix of potential upside and flagged concerns in view, use this moment to review the full picture and weigh both sides for yourself, starting with the 4 key rewards and 1 important warning sign
Looking for more investment ideas beyond CBIZ?
If CBIZ has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to uncover more targeted stock ideas that fit your approach.
- Target potential mispricing by scanning for companies that combine quality fundamentals with attractive valuations through the 43 high quality undervalued stocks
- Prioritise resilience by reviewing stocks that show robust finances and prudent leverage using the solid balance sheet and fundamentals stocks screener (47 results)
- Hunt for underfollowed opportunities by tapping into the screener containing 19 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com